What might be the place of cardioneuroablation strategy in syncope guideline? [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. Ahead of Print: TKDA-10187 | DOI: 10.5543/tkda.2018.10187

What might be the place of cardioneuroablation strategy in syncope guideline?

Tolga Aksu1, Tumer Erdem Guler1, Serdar Bozyel1, Kivanc Yalin2
1Kocaeli Derince Education And Research Hospital, Department Of Cardiology, Kocaeli, Turkey
2Usak University, Faculty of Medicine, Department of Cardiology, Uşak, Turkey

Vasovagal syncope (VVS) is the most common type of syncope. Although it is not related to an increase in mortality, recurrent syncope episodes may be disabling and reduce the quality of life. No optimal treatment strategies are currently available especially for the cardioinhibitory type of VVS. Cardioneuroablation (CNA) is a relatively novel technique which intends to abolish the vagal efferent output during VVS. We aimed to find a possible answer to following question: what might be the place of CNA strategy in syncope guidelines in this review article.

Keywords: Parasympathetic, bradycardia, vagal ganglia, ganglionated plexi, fat pads

How to cite this article


Corresponding Author: Tolga Aksu, Türkiye
© Copyright 2018 Archives of the Turkish Society of Cardiology
LookUs & Online Makale